3 completed, 1 active not recruiting. 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Completed 1 |
Follow Male Osteoporosis: new trials by email Literature Review of Male Osteoporosis trials Research Report on Male Osteoporosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| OST and MORES in Male Osteoporosis Male Osteoporosis | Active not recruiting | Kayseri City Hospital | 140 | 2026-02-04 | 2026-04-08 | |
| Novel Combination Therapy for Osteoporosis in Men Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, placebo tablet - Male Osteoporosis | Phase 4 | Completed | VA Office of Research and Development | 40 | 2019-07-01 | 2026-09-03 |
| The Effect Of Oral Ibandronate In Male Osteoporosis Ibandronate, placebo - Male Osteoporosis | Phase 3 | Completed | Hoffmann-La Roche | 135 | 2007-01-01 | 2009-12-21 |
| Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis Zoledronic acid 5 mg iv, Placebo - Male Osteoporosis | Phase 3 | Completed | Novartis Pharmaceuticals | 1199 | 2006-12-01 | 2017-04-21 |
Osteoporosis (2) · Spinal Fractures (1)
Bone Diseases (2) · Bone Diseases, Metabolic (2) · Metabolic Diseases (2) · Musculoskeletal Diseases (2) · Nutritional and Metabolic Diseases (2) · Back Injuries (1) · Fractures, Bone (1) · Spinal Injuries (1) · Wounds and Injuries (1)
Calcium Citrate (1) · Cholecalciferol (1) · Cinacalcet (1) · Ibandronic Acid (1) · PTH protein, human (1) · Teriparatide (1) · Zoledronic Acid (1)
Hoffmann-La Roche (1) · Kayseri City Hospital (1) · Novartis Pharmaceuticals (1) · VA Office of Research and Development (1)
United States (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Hungary (1) · Iceland (1) · Italy (1) · Norway (1) · Poland (1)